Bryn Mawr Capital Management LLC Has $1.90 Million Holdings in CME Group Inc. (NASDAQ:CME)

Bryn Mawr Capital Management LLC decreased its position in shares of CME Group Inc. (NASDAQ:CME) by 80.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,189 shares of the financial services provider’s stock after selling 33,805 shares during the quarter. Bryn Mawr Capital Management LLC’s holdings in CME Group were worth $1,902,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Global Retirement Partners LLC increased its position in shares of CME Group by 453.8% during the fourth quarter. Global Retirement Partners LLC now owns 13,425 shares of the financial services provider’s stock worth $3,118,000 after acquiring an additional 11,001 shares in the last quarter. Convergence Investment Partners LLC boosted its stake in CME Group by 14.2% during the 4th quarter. Convergence Investment Partners LLC now owns 5,760 shares of the financial services provider’s stock valued at $1,338,000 after purchasing an additional 717 shares during the last quarter. Bank of Jackson Hole Trust bought a new stake in CME Group during the 4th quarter worth approximately $307,000. New York State Common Retirement Fund increased its holdings in CME Group by 25.4% during the 4th quarter. New York State Common Retirement Fund now owns 615,241 shares of the financial services provider’s stock worth $142,877,000 after purchasing an additional 124,800 shares in the last quarter. Finally, Kentucky Retirement Systems Insurance Trust Fund raised its stake in shares of CME Group by 4.7% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 11,163 shares of the financial services provider’s stock worth $2,592,000 after purchasing an additional 502 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CME has been the topic of several analyst reports. Morgan Stanley lifted their target price on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday. Deutsche Bank Aktiengesellschaft cut their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Citigroup downgraded shares of CME Group from a “buy” rating to a “neutral” rating and lowered their target price for the company from $255.00 to $250.00 in a report on Monday, January 6th. Barclays boosted their price target on shares of CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Finally, JPMorgan Chase & Co. increased their price objective on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research note on Thursday, February 13th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus price target of $236.13.

CME Group Trading Down 1.0 %

NASDAQ:CME opened at $248.32 on Friday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $253.53. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm’s 50 day moving average is $236.87 and its 200 day moving average is $227.00. The stock has a market capitalization of $89.48 billion, a PE ratio of 25.68, a price-to-earnings-growth ratio of 6.77 and a beta of 0.57.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Sell-side analysts expect that CME Group Inc. will post 10.45 earnings per share for the current year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be issued a $1.25 dividend. The ex-dividend date is Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 2.01%. CME Group’s dividend payout ratio is 47.57%.

CME Group declared that its board has authorized a stock buyback plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board believes its shares are undervalued.

Insiders Place Their Bets

In other CME Group news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This trade represents a 34.63 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.